Stock listing

Syndax Pharmaceuticals, Inc.

Selected listing: A2AFL6 · LS · EUR · DE

Syndax Pharmaceuticals, Inc. (Lang & Schwarz: A2AFL6), Health Technology. Latest release Oct 2, 2026: Syndax Pharmaceuticals Reports Inducement Grants Under…

A2AFL6:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A2AFL6
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

October 2, 2026

Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update

August 4, 2026

Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026

July 28, 2026

Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event

July 14, 2026

Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026

June 11, 2026

All Syndax Pharmaceuticals, Inc. news →

Events

Replays

Syndax Pharmaceuticals, Inc. (SNDX) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 04:30 PM ET
Watch
Syndax Pharmaceuticals, Inc. (SNDX) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 04:30 PM ET
Watch
Syndax Pharmaceuticals, Inc. (SNDX) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 07:30 PM ET
Watch

Research Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc. company profile

View the public company page for Syndax Pharmaceuticals, Inc. on 6ix.

Syndax Pharmaceuticals, Inc. news

Read company news and market updates connected to Syndax Pharmaceuticals, Inc..

Syndax Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Syndax Pharmaceuticals, Inc..